c-Met Method for seleting genes for normalization for detecting copy number variation and composition for detecting copy number variation of c-Met by using the same
본 발명은 c-Met 유전자의 CNV 검출용 프라이머 및 프로브 세트 조성물과 이를 포함하는 키트에 관한 것이다. 본 발명에 따른 CNV 검출용 프라이머 및 프로브 세트 조성물을 이용하여 c-Met이 발현되는 암 환자의 예후 또는 돌연변이 발생 위험도 예측이 가능하며, 암의 표적 치료에 필요한 정보를 제공할 수 있어 항암치료제의 투여 필요성 판단을 비롯하여 향후 치료의 방향에 대한 단서를 제시하는 목적 및 암의 전이 또는 재발에 대한 모니터링 하는 데에 유용하게 이용될 수 있다. The present invention relates...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JUNG YUN JUNG KIM SUNG SU CHOI JUN YOUNG NAM JI HYE KIM HA EUN PARK KYUNG EUI |
| description | 본 발명은 c-Met 유전자의 CNV 검출용 프라이머 및 프로브 세트 조성물과 이를 포함하는 키트에 관한 것이다. 본 발명에 따른 CNV 검출용 프라이머 및 프로브 세트 조성물을 이용하여 c-Met이 발현되는 암 환자의 예후 또는 돌연변이 발생 위험도 예측이 가능하며, 암의 표적 치료에 필요한 정보를 제공할 수 있어 항암치료제의 투여 필요성 판단을 비롯하여 향후 치료의 방향에 대한 단서를 제시하는 목적 및 암의 전이 또는 재발에 대한 모니터링 하는 데에 유용하게 이용될 수 있다.
The present invention relates to a primer and probe set composition for CNV detection of a c-Met gene, and a kit comprising the same. By using the primer and probe set composition for CNV detection according to the present invention, it is possible to predict a prognosis of a c-Met-expressing cancer patient or a risk of mutation occurrence and to provide information required for targeted therapy of cancer, so as to be effectively used to provide clues for future treatment directions, as well as to determine a need to administer an anticancer drug, and to monitor the metastasis or recurrence of cancer. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240087622A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240087622A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240087622A3</originalsourceid><addsrcrecordid>eNqNjkEKwjAURLtxIeodPrgulCjqVkQRxI24L2n60waa_JCfCvU8HtTaeoAuhoGZNzDz5KPSO0boVVMJmgIwNhiNq6BChzxEjoKVjXnLaMgNSYkR1UAp8h241hYY4CWDGRnpyr6xnthM3pCG8UzRQcs_LtYILC0uk5mWDePq74tkfTk_T9cUPeXIXqr-asxvD5GJbZYd9jshjptp1BcA_Vd6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>c-Met Method for seleting genes for normalization for detecting copy number variation and composition for detecting copy number variation of c-Met by using the same</title><source>esp@cenet</source><creator>JUNG YUN JUNG ; KIM SUNG SU ; CHOI JUN YOUNG ; NAM JI HYE ; KIM HA EUN ; PARK KYUNG EUI</creator><creatorcontrib>JUNG YUN JUNG ; KIM SUNG SU ; CHOI JUN YOUNG ; NAM JI HYE ; KIM HA EUN ; PARK KYUNG EUI</creatorcontrib><description>본 발명은 c-Met 유전자의 CNV 검출용 프라이머 및 프로브 세트 조성물과 이를 포함하는 키트에 관한 것이다. 본 발명에 따른 CNV 검출용 프라이머 및 프로브 세트 조성물을 이용하여 c-Met이 발현되는 암 환자의 예후 또는 돌연변이 발생 위험도 예측이 가능하며, 암의 표적 치료에 필요한 정보를 제공할 수 있어 항암치료제의 투여 필요성 판단을 비롯하여 향후 치료의 방향에 대한 단서를 제시하는 목적 및 암의 전이 또는 재발에 대한 모니터링 하는 데에 유용하게 이용될 수 있다.
The present invention relates to a primer and probe set composition for CNV detection of a c-Met gene, and a kit comprising the same. By using the primer and probe set composition for CNV detection according to the present invention, it is possible to predict a prognosis of a c-Met-expressing cancer patient or a risk of mutation occurrence and to provide information required for targeted therapy of cancer, so as to be effectively used to provide clues for future treatment directions, as well as to determine a need to administer an anticancer drug, and to monitor the metastasis or recurrence of cancer.</description><language>eng ; kor</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240619&DB=EPODOC&CC=KR&NR=20240087622A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240619&DB=EPODOC&CC=KR&NR=20240087622A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JUNG YUN JUNG</creatorcontrib><creatorcontrib>KIM SUNG SU</creatorcontrib><creatorcontrib>CHOI JUN YOUNG</creatorcontrib><creatorcontrib>NAM JI HYE</creatorcontrib><creatorcontrib>KIM HA EUN</creatorcontrib><creatorcontrib>PARK KYUNG EUI</creatorcontrib><title>c-Met Method for seleting genes for normalization for detecting copy number variation and composition for detecting copy number variation of c-Met by using the same</title><description>본 발명은 c-Met 유전자의 CNV 검출용 프라이머 및 프로브 세트 조성물과 이를 포함하는 키트에 관한 것이다. 본 발명에 따른 CNV 검출용 프라이머 및 프로브 세트 조성물을 이용하여 c-Met이 발현되는 암 환자의 예후 또는 돌연변이 발생 위험도 예측이 가능하며, 암의 표적 치료에 필요한 정보를 제공할 수 있어 항암치료제의 투여 필요성 판단을 비롯하여 향후 치료의 방향에 대한 단서를 제시하는 목적 및 암의 전이 또는 재발에 대한 모니터링 하는 데에 유용하게 이용될 수 있다.
The present invention relates to a primer and probe set composition for CNV detection of a c-Met gene, and a kit comprising the same. By using the primer and probe set composition for CNV detection according to the present invention, it is possible to predict a prognosis of a c-Met-expressing cancer patient or a risk of mutation occurrence and to provide information required for targeted therapy of cancer, so as to be effectively used to provide clues for future treatment directions, as well as to determine a need to administer an anticancer drug, and to monitor the metastasis or recurrence of cancer.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjkEKwjAURLtxIeodPrgulCjqVkQRxI24L2n60waa_JCfCvU8HtTaeoAuhoGZNzDz5KPSO0boVVMJmgIwNhiNq6BChzxEjoKVjXnLaMgNSYkR1UAp8h241hYY4CWDGRnpyr6xnthM3pCG8UzRQcs_LtYILC0uk5mWDePq74tkfTk_T9cUPeXIXqr-asxvD5GJbZYd9jshjptp1BcA_Vd6</recordid><startdate>20240619</startdate><enddate>20240619</enddate><creator>JUNG YUN JUNG</creator><creator>KIM SUNG SU</creator><creator>CHOI JUN YOUNG</creator><creator>NAM JI HYE</creator><creator>KIM HA EUN</creator><creator>PARK KYUNG EUI</creator><scope>EVB</scope></search><sort><creationdate>20240619</creationdate><title>c-Met Method for seleting genes for normalization for detecting copy number variation and composition for detecting copy number variation of c-Met by using the same</title><author>JUNG YUN JUNG ; KIM SUNG SU ; CHOI JUN YOUNG ; NAM JI HYE ; KIM HA EUN ; PARK KYUNG EUI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240087622A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>JUNG YUN JUNG</creatorcontrib><creatorcontrib>KIM SUNG SU</creatorcontrib><creatorcontrib>CHOI JUN YOUNG</creatorcontrib><creatorcontrib>NAM JI HYE</creatorcontrib><creatorcontrib>KIM HA EUN</creatorcontrib><creatorcontrib>PARK KYUNG EUI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JUNG YUN JUNG</au><au>KIM SUNG SU</au><au>CHOI JUN YOUNG</au><au>NAM JI HYE</au><au>KIM HA EUN</au><au>PARK KYUNG EUI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>c-Met Method for seleting genes for normalization for detecting copy number variation and composition for detecting copy number variation of c-Met by using the same</title><date>2024-06-19</date><risdate>2024</risdate><abstract>본 발명은 c-Met 유전자의 CNV 검출용 프라이머 및 프로브 세트 조성물과 이를 포함하는 키트에 관한 것이다. 본 발명에 따른 CNV 검출용 프라이머 및 프로브 세트 조성물을 이용하여 c-Met이 발현되는 암 환자의 예후 또는 돌연변이 발생 위험도 예측이 가능하며, 암의 표적 치료에 필요한 정보를 제공할 수 있어 항암치료제의 투여 필요성 판단을 비롯하여 향후 치료의 방향에 대한 단서를 제시하는 목적 및 암의 전이 또는 재발에 대한 모니터링 하는 데에 유용하게 이용될 수 있다.
The present invention relates to a primer and probe set composition for CNV detection of a c-Met gene, and a kit comprising the same. By using the primer and probe set composition for CNV detection according to the present invention, it is possible to predict a prognosis of a c-Met-expressing cancer patient or a risk of mutation occurrence and to provide information required for targeted therapy of cancer, so as to be effectively used to provide clues for future treatment directions, as well as to determine a need to administer an anticancer drug, and to monitor the metastasis or recurrence of cancer.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20240087622A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
| title | c-Met Method for seleting genes for normalization for detecting copy number variation and composition for detecting copy number variation of c-Met by using the same |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T05%3A34%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JUNG%20YUN%20JUNG&rft.date=2024-06-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240087622A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |